Seung K Kim, MD
Plastic Surgery · Palo Alto
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kim’s office at (650) 325-2530 to ask if they take your plan before you enroll.
California Medical Board record
Licence G36786 · Current
Licensed to practise in California · since 1978 · expires 2028-01-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- Plastic Surgery Center, LLCOffice-Based Surgery Center · Palo Alto, CA24.6% owner since 2012 · accredited by AAAASFAccreditation Renewed4 inspections, 3 with deficiencies · last 2023-11-16: Requirements Met
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Plastic Surgery - Plastic Surgery
Drugs they prescribed that Part D paid
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 48% of their 23 Part D prescriptions in 2022. Too few prescriptions to judge: with under about 50 a year, a handful of patients can swing this share.
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
Year by year
| 2023 | 29 | None | None | None | $421 |
| 2022 | 23 | 12 | 48% (11) | 0% | $220 |
| 2020 | 12 | None | None | None | $2,753 |
| 2019 | 26 | None | None | None | $3,499 |
| 2016 | 22 | 11 | None | None | $235 |
| 2015 | 29 | 15 | 38% (11) | None | $3,124 |
| 2014 | 101 | 24 | None | None | $7,802 |
| 2013 | 220 | 31 | 7% (15) | 31% | $22,879 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2014: 2 drugs
| Levothyroxine | 14 | $197 | $14 |
| Glipizide | 11 | $75 | $7 |
2013: 8 drugs
| Insulin | 22 | $615 | $28 |
| Metformin Hcl Er | 22 | $487 | $22 |
| Levothyroxine | 27 | $355 | $13 |
| Metformin | 15 | $216 | $14 |
| Gabapentin | 11 | $158 | $14 |
| Oxycodone-Acetaminophen | 12 | $94 | $8 |
| Lisinopril | 16 | $89 | $6 |
| Simvastatin | 11 | $83 | $8 |
Money from drug and device companies
$27 in 2021
| 2021 | 1 | 1 | None | $27 |
| 2020 | 2 | 2 | None | $45 |
| 2019 | 1 | 6 | None | $105 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Allergan | None | $27 | 1 payment
|
See the published payment
| Allergan | Meals · 2021-10-26 | None | $27 |
See earlier years (2020, 2019)
2020: $45
| Galderma Laboratories L.P. | None | $24 | 1 payment
|
| Allergan | Botox Cosmetic | $21 | 1 payment
|
2019: $105
| Galderma Laboratories L.P. | None | $105 | 6 payments
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Allergan Inc. · Breast Implant Follow-Up Studies · 2019 | Their institution | $20 |
Professional record
- NPI
- 1962532812
- Licence
- CA G36786California G36786: Current · expires 2028-01-31
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 208200000X (208200000X)
- Mailing address
- 1515 El Camino Real, Suite F, Palo Alto, CA, 94306
- NPI first listed
- 2007-03-07
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.